{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05935605",
            "orgStudyIdInfo": {
                "id": "17-008263"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R01HL162828-01A1",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R01HL162828-01A1"
                }
            ],
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Pulmonary Hypertension in Left Heart Disease",
            "officialTitle": "Comparison of Noninvasively-Obtained Echocardiographic Doppler Parameters With Simultaneously-Measured Invasive Hemodynamics in Patients Referred for Right Heart Catheterization",
            "therapeuticArea": [
                "Respiratory",
                "Cardiovascular"
            ],
            "study": "pulmonary-hypertension-in-left-heart-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-29",
            "studyFirstSubmitQcDate": "2023-06-29",
            "studyFirstPostDateStruct": {
                "date": "2023-07-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Barry Borlaug",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal is to compare patients with and without varying severity of pulmonary vascular disease based upon hemodynamic signatures, echocardiographic measures, and lung ultrasound, in tandem with expired gas metabolic testing and blood sampling."
        },
        "conditionsModule": {
            "conditions": [
                "Pulmonary Hypertension",
                "Pulmonary Vascular Disease",
                "Left Heart Disease"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "CROSS_SECTIONAL"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITHOUT_DNA",
                "description": "Blood samples from the pulmonary artery and systemic artery will be collected at rest \\& during exercise portion of the cardiac catheterization procedure in EDTA tubes \\& stored for future discovery-based analyses."
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LHD with no PH",
                    "description": "Subjects with Left Heart Disease (LHD) and no Pulmonary Hypertension (PH; mean pulmonary artery (PA) pressure \u226420 mmHg) that are already referred for invasive hemodynamic assessment by right heart catheterization for clinical reasons will undergo transthoracic echocardiography and lung ultrasound.",
                    "interventionNames": [
                        "Diagnostic Test: Transthoracic Echocardiography (TTE)",
                        "Diagnostic Test: Lung ultrasound"
                    ]
                },
                {
                    "label": "LHD with isolated PVH",
                    "description": "Subjects with Left Heart Disease (LHD) and isolated Pulmonary Venous Hypertension (PVH; mean PA pressure\\>20 mmHg and PVR\\<3 WU) that are already referred for invasive hemodynamic assessment by right heart catheterization for clinical reasons will undergo transthoracic echocardiography and lung ultrasound.",
                    "interventionNames": [
                        "Diagnostic Test: Transthoracic Echocardiography (TTE)",
                        "Diagnostic Test: Lung ultrasound"
                    ]
                },
                {
                    "label": "LHD with vasoactive PVD",
                    "description": "Subjects with Left Heart Disease (LHD) and vasoactive Pulmonary Vascular Disease (PVD; mean PA pressure\\>20 mmHg and PVR\u22653 WU with \u226520% reduction in PVR with inhaled nitric oxide) that are already referred for invasive hemodynamic assessment by right heart catheterization for clinical reasons will undergo transthoracic echocardiography and lung ultrasound.",
                    "interventionNames": [
                        "Diagnostic Test: Transthoracic Echocardiography (TTE)",
                        "Diagnostic Test: Lung ultrasound"
                    ]
                },
                {
                    "label": "LHD with fixed PVD",
                    "description": "Subjects with Left Heart Disease (LHD) and fixed Pulmonary Vascular Disease (PVD; mean PA pressure\\>20 mmHg, PVR\u22653 WU, and PVR reduction of \\<20% with inhaled nitric oxide) that are already referred for invasive hemodynamic assessment by right heart catheterization for clinical reasons will undergo transthoracic echocardiography and lung ultrasound.",
                    "interventionNames": [
                        "Diagnostic Test: Transthoracic Echocardiography (TTE)",
                        "Diagnostic Test: Lung ultrasound"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Transthoracic Echocardiography (TTE)",
                    "description": "Transthoracic echocardiography using ultrasound waves will be conducted during the rest and exercise phases of the clinically indicated invasive hemodynamic assessment by right heart catheterization to gather additional measurements of right ventricular function.",
                    "armGroupLabels": [
                        "LHD with fixed PVD",
                        "LHD with isolated PVH",
                        "LHD with no PH",
                        "LHD with vasoactive PVD"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Lung ultrasound",
                    "description": "A lung ultrasound, which uses sound waves to produce images of the lungs, will be used to assess extravascular lung fluid during the rest and exercise phases of the clinically indicated invasive hemodynamic assessment by right heart catheterization.",
                    "armGroupLabels": [
                        "LHD with fixed PVD",
                        "LHD with isolated PVH",
                        "LHD with no PH",
                        "LHD with vasoactive PVD"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Peak Exercise Cardiac Output",
                    "description": "Peak exercise cardiac output (L/min) will be measured using the direct Fick technique during the invasive hemodynamic assessment by right heart catheterization.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Peak Exercise Oxygen Consumption (VO2)",
                    "description": "Peak exercise VO2 (ml/kg/min) will be measured using expired gas analysis collected during the invasive hemodynamic assessment by right heart catheterization.",
                    "timeFrame": "Baseline"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Right Ventricular function assessed by Tricuspid Annular Plane Systolic Excursion (TAPSE)",
                    "description": "TAPSE is measured as the displacement (in mm) of the lateral tricuspid annulus toward the apex during systole measured using transthoracic echocardiography during the invasive hemodynamic assessment by right heart catheterization.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Right Ventricular function assessed by tricuspid annular plane systolic excursion (TAPSE)/systolic pulmonary artery pressure (PASP) ratio",
                    "description": "TAPSE/PASP ratio (mm/mmHg) will be measured using transthoracic echocardiography during the invasive hemodynamic assessment by right heart catheterization.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Extravascular Lung Fluid Content (B-line score)",
                    "description": "Extravascular Lung Fluid Content (B-line score) will be measured using lung ultrasound during the invasive hemodynamic assessment by right heart catheterization.",
                    "timeFrame": "Baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients referred to the cardiac catheterization laboratory for invasive right heart catheterization for any reason.\n* Left Heart Disease, defined as one (or more) of the following:\n\n  * Symptomatic HFpEF, defined by signs and symptoms of HF (dyspnea, fatigue), normal left ventricular (LV) EF (\u226550% within 12 months of enrollment), and objective evidence of HF fulfilling at least one of the following criteria: Prior hospitalization for decompensated HF treated with intravenous diuretics; Invasively verified HFpEF defined by pulmonary capillary wedge pressure (PCWP) of \u226515 mmHg at rest and/or \u226525 mmHg during exercise; Clinical diagnosis of HFpEF that does not meet criteria i. or ii. but verified with NTproBNP\\>300 pg/ml in sinus rhythm or \\>900 pg/ml in AF; H2FPEF score \u22656 or HFA-PEFF score\u22655 according to current guidelines.\n  * Symptomatic HFrEF, defined by defined by signs and symptoms of HF (dyspnea, fatigue) and reduced EF (\\<50%).\n  * Symptomatic valvular heart disease (VHD), defined by signs and symptoms of HF (dyspnea, fatigue) in tandem with clinically significant aortic or mitral valve disease (regurgitation and/or stenosis).\n\nExclusion Criteria:\n\n* Patient inability or unwillingness to undergo noninvasive echocardiography, or if echocardiography would, in the opinion of the investigator, somehow compromise the quality of data acquisition for the clinical case.\n* WSPH Group 1 Pulmonary hypertension or PH (Pulmonary arterial hypertension; including congenital heart disease)\n* Group 3 PH (Hypoxia/Lung disease-related PH)\n* Group 4 PH (Thromboembolic PH)\n* Group 5 PH (Miscellaneous)\n* Clinically significant parenchymal lung disease, hypoxemia, or lung infection\n* Amyloid/infiltrative cardiomyopathy\n* Acute Myocarditis\n* Acute coronary syndrome or revascularization within 90 days\n* Use of PH-specific drugs\n* Constrictive pericarditis\n* High output heart failure\n* HF hospitalization within the preceding 30 days\n* Severe or greater aortic (AVA \\< 1.0 cm2, Mean Gradient \\> 40 mmHg) or severe mitral (MVA \\< 1.0 cm) stenosis\n* Inability or unwillingness to exercise\n* Inadequate echocardiographic imaging windows\n* Inability or unwillingness to cooperate with breath holding",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients with known or suspected Left Heart Disease (LHD) that are already referred for invasive hemodynamic assessment by right heart catheterization for clinical reasons at Mayo Clinic in Rochester, MN will be identified and approached for participation.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Circulatory Failure Research Team",
                    "role": "CONTACT",
                    "phone": "(507) 255-2200"
                },
                {
                    "name": "Barry Borlaug, MD",
                    "role": "CONTACT",
                    "phone": "(507) 255-4152",
                    "email": "Borlaug.Barry@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Barry Borlaug, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Circulatory Failure Research Team",
                            "role": "CONTACT",
                            "phone": "507-255-2200"
                        },
                        {
                            "name": "Barry Borlaug, MD",
                            "role": "CONTACT",
                            "phone": "(507) 255-4152",
                            "email": "Borlaug.Barry@mayo.edu"
                        },
                        {
                            "name": "Barry Borlaug, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006976",
                    "term": "Hypertension, Pulmonary"
                },
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10027",
                    "name": "Hypertension, Pulmonary",
                    "asFound": "Pulmonary Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "asFound": "Heart Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "asFound": "Vascular Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M12507",
                    "name": "Nitric Oxide",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}